Two-dose measles vaccine effectiveness remains high over time: A French observational study, 2017–2019
Open Access
- 14 August 2023
- Vol. 41 (39) , 5797-5804
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Measles Elimination Efforts and 2008–2011 Outbreak, FranceEmerging Infectious Diseases, 2013
- Two Case Studies of Modified Measles in Vaccinated Physicians Exposed to Primary Measles Cases: High Risk of Infection But Low Risk of TransmissionThe Journal of Infectious Diseases, 2011
- An assessment of mumps vaccine effectiveness by dose during an outbreak in CanadaCanadian Medical Association Journal, 2011
- Persistence of Measles, Mumps, and Rubella Antibodies in an MMR‐Vaccinated Cohort: A 20‐Year Follow‐upThe Journal of Infectious Diseases, 2008
- Persistence of Measles Antibodies After 2 Doses of Measles Vaccine in a Postelimination EnvironmentArchives of Pediatrics & Adolescent Medicine, 2007
- Persistence of Vaccine-Induced Antibody to Measles 26–33 Years after VaccinationThe Journal of Infectious Diseases, 2004
- The Clinical Significance of Measles: A ReviewThe Journal of Infectious Diseases, 2004
- Measles: not just another viral exanthemThe Lancet, 2003
- Estimation of Vaccine Effectiveness Using the Screening MethodInternational Journal of Epidemiology, 1993
- Six Years of Public Health Surveillance of Measles in FranceInternational Journal of Epidemiology, 1992